Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Atorvastatin and Ezetimibe in Patients with Acute Coronary Syndrome
Author(s): Mohammed Sallam , Hossameldin Hassan , Derek Connolly , et al Added: 6 months ago

Prevention & Chronic Conditions

MI/ACS
ESC 23: New Guidelines For the Management of Acute Coronary Syndromes
Author(s): Robert A Byrne Added: 1 year ago
ESC 2023 — Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes. Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation… View more

Guidelines & Statements

MI/ACS
Symptomology, Outcomes and Risk Factors of Acute Coronary Syndrome Presentations without Cardiac Chest Pain: A Scoping Review
Author(s): Meriem Perona , Amanda Cooklin , Christopher Thorpe , et al Added: 10 months ago

MI/ACS
Prognostic Utility of the ABCD-GENE Score in Asian ACS Patients
Author(s): Cheng Keat Tan , David Bin-Chia Wu , Seh Yi Joseph Tan , et al Added: 1 year ago

Anticoagulation

MI/ACS
ESC 23: The STOPDAPT-3 Study
Author(s): Masahiro Natsuaki Added: 1 year ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111). In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at… View more

MI/ACS

Intervention
A Preferred Substrate-based Nomenclature in Myocardial Ischaemic Syndromes
Author(s): William E Boden , Juan Carlos Kaski , C Noel Bairey Merz , et al Added: 2 weeks ago

MI/ACS
Updates on Chronic Coronary Syndrome
Author(s): Filippo Gurgoglione , Giampaolo Niccoli Added: 5 months ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Could Acute COVID-19 Infection Ignite Thrombotic Risk?
Author(s): Joshua Stolker , Philippe Gabriel Steg , Roberta Rossini , et al Added: 3 days ago

COVID-19

MI/ACS
Evolution of Coronary Artery Spasm
Author(s): John F Beltrame , Peter Ong , Filippo Crea Added: 1 year ago

Prevention & Chronic Conditions
Could Acute COVID-19 Infection Ignite Thrombotic Risk?
Author(s): Naveed Sattar , Philippe Gabriel Steg , Lale Tokgözoğlu , et al Added: 11 months ago
Watch this on-demand programme chaired by Prof Naveed Sattar (School of Cardiovascular and Metabolic Health, Glasgow, UK). Radcliffe Cardiology presents a distinguished panel of experts: Prof Gabriel Steg (University Institute of France, Paris, FR), Prof Lale Tokgozoglu (Hacettepe University, Ankara, TR), and Dr Joshua Stolker (St Louis Hospital, Missouri, US). This roundtable discussion explores… View more

COVID-19